Top

Open Access 14-03-2024 | Original Article

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors

Authors: A. Rizzo, M. Paderno, M. F. Saccomanno, F. Milano, G. Milano

Abstract

Purpose

The main purpose of the present study was to evaluate if there is a difference between objective or subjective administration of the MSTS score in a cohort of patients affected by musculoskeletal oncological diseases.

Materials and methods

All patients who underwent surgery for bone or soft tissue localization of neoplastic disease in lower or upper limb from June 2015 to June 2020 were considered eligible. In order to administer the score as a PROM, the MSTS was first translated and cross-culturally adapted in Italian. During follow up visits, all patients filled out Italian versions of SF36, TESS and MSTS. Psychometric properties of the Italian version of MSTS were analyzed. Correlation between objective and self-administered MSTS score was assessed through Pearson’s coefficient.

Results

A finale sample of 110 patients were included: 59 affected by lower extremity involvement and 51 affected by upper extremity involvement. The Italian version of the MSTS score showed good psychometric properties for both lower and upper extremity. The correlation between self-administered and hetero-administered version of the questionnaire was as high as r = 0.97 for lower extremities and r = 0.96 for upper extremities.

Conclusions

The Italian version of the MSTS is a valid tool to evaluate outcomes of surgical treatment of patients affected by extremities tumors and it can be used as a subjective tool for both lower and upper extremity.

Available only for authorised users

Valderas JM, Kotzeva A, Espallargues M et al (2008) The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 17:179–193. https://doi.org/10.1007/s11136-007-9295-0CrossRefPubMed

Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211. https://doi.org/10.1186/1472-6963-13-211CrossRefPubMedPubMedCentral

Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S (2015) Patient reported outcome measures in practice

Enneking W (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. 286:241–246

Bolia IK, Savvidou OD, Kang HP et al (2021) Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece. Eur J Orthop Surg Traumatol. https://doi.org/10.1007/s00590-021-02921-5CrossRefPubMedPubMedCentral

Saebye CKP, Keller J, Baad-Hansen T (2019) Validation of the Danish version of the musculoskeletal tumour society score questionnaire. World J Orthop 10:23–32. https://doi.org/10.5312/wjo.v10.i1.23CrossRefPubMedPubMedCentral

Rebolledo DCS, Vissoci JRN, Pietrobon R et al (2013) Validation of the Brazilian version of the Musculoskeletal Tumor Society rating scale for lower extremity bone sarcoma. Clin Orthop 471:4020–4026. https://doi.org/10.1007/s11999-013-3211-4CrossRefPubMedPubMedCentral

Xu L, Li X, Wang Z et al (2017) Functional evaluation for patients with lower extremity sarcoma: application of the Chinese version of Musculoskeletal Tumor Society scoring system. Health Qual Life Outcomes 15:107. https://doi.org/10.1186/s12955-017-0685-xCrossRefPubMedPubMedCentral

Uehara K, Ogura K, Akiyama T et al (2017) Reliability and validity of the Musculoskeletal Tumor Society Scoring system for the upper extremity in Japanese patients. Clin Orthop 475:2253–2259. https://doi.org/10.1007/s11999-017-5390-xCrossRefPubMedPubMedCentral

10.

Mallet J, El Kinani M, Crenn V et al (2023) French translation and validation of the cross-cultural adaptation of the MSTS functional assessment questionnaire completed after tumor surgery. Orthop Traumatol Surg Res 109:103574. https://doi.org/10.1016/j.otsr.2023.103574CrossRefPubMed

11.

Ocaktan B, Deveci MA et al (2021) Cross-cultural adaptation and validation of the Turkish version of the Musculoskeletal Tumor Society scoring system in patients with musculoskeletal tumors. Acta Orthop Traumatol Turc 55:141–146. https://doi.org/10.5152/j.aott.2021.20195CrossRefPubMed

12.

Enneking WF et al (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106–120CrossRef

13.

Enneking W (1987) Modification of the system for functional evaluation of surgical Management of Musculoskeletal Tumors. N. Y. NY Churchill-Livingstone

14.

Karnofsky DA, Burchenal JH (1949) Evaluation of chemotherapeutic agents. Clin Eval Chemother Agents Cancer 191–205

15.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191. https://doi.org/10.1097/00007632-200012150-00014CrossRefPubMed

16.

Guillemin F, Bombardier C, Beaton D (1993) Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432. https://doi.org/10.1016/0895-4356(93)90142-NCrossRefPubMed

17.

Rossi L, Boffano M, Comandone A et al (2020) Validation process of Toronto Exremity Salvage Score in Italian: a quality of life measure for patients with extremity bone and soft tissue tumors. J Surg Oncol 121:630–637. https://doi.org/10.1002/jso.25849CrossRefPubMed

18.

Apolone G, Mosconi P. The Italian SF-36 health survey: translation, validation and norming. 12

19.

Davis AM, Wright JG, Williams JI et al (1996) Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res 5:508–516. https://doi.org/10.1007/BF00540024CrossRefPubMed

20.

Ursachi G, Horodnic IA, Zait A (2015) How reliable are measurement scales? External factors with indirect influence on reliability estimators. Procedia Econ Finance 20:679–686. https://doi.org/10.1016/S2212-5671(15)00123-9CrossRef

21.

Artino AR, La Rochelle JS, Dezee KJ, Gehlbach H (2014) Developing questionnaires for educational research: AMEE Guide No. 87. Med Teach 36:463–474. https://doi.org/10.3109/0142159X.2014.889814CrossRefPubMedPubMedCentral

22.

Downie S, Stillie A, Moran M et al (2021) Patient-reported assessment of outcome after surgery for bone metastases. Orthop Rev. https://doi.org/10.4081/or.2021.9062CrossRef

23.

Marchese VG, Rai SN, Carlson CA et al (2007) Assessing functional mobility in survivors of lower-extremity sarcoma: reliability and validity of a new assessment tool. Pediatr Blood Cancer 49:183–189. https://doi.org/10.1002/pbc.20932CrossRefPubMed

24.

Ginsberg JP, Rai SN, Carlson CA et al (2007) A comparative analysis of functional outcomes in adolescents and young adults with lower-extremity bone sarcoma. Pediatr Blood Cancer 49:964–969. https://doi.org/10.1002/pbc.21018CrossRefPubMed

25.

Janssen SJ, van Rein EAJ, Paulino Pereira NR et al (2016) The discrepancy between patient and clinician reported function in extremity bone metastases. Sarcoma 2016:1–6. https://doi.org/10.1155/2016/1014248CrossRef

26.

Iwata S, Uehara K, Ogura K et al (2016) Reliability and validity of a Japanese-language and culturally adapted version of the musculoskeletal tumor society scoring system for the lower extremity. Clin Orthop Relat Res 474:2044–2052CrossRefPubMedPubMedCentral

27.

Wada T, Kawai A, Ihara K et al (2007) Construct validity of the Enneking score for measuring function in patients with malignant or aggressive benign tumours of the upper limb. J Bone Jt Surg 89:5

28.

Hulin C, Netemeyer R, Cudeck R (2001) Can a reliability coefficient be too high? 10(1):55–58

Title: The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors
Authors: A. Rizzo
M. Paderno
M. F. Saccomanno
F. Milano
G. Milano
Publication date: 14-03-2024
Publisher: Springer Milan
Published in: MUSCULOSKELETAL SURGERY
Print ISSN: 2035-5106
Electronic ISSN: 2035-5114
DOI: https://doi.org/10.1007/s12306-024-00815-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Musculoskeletal Tumor Society Scoring system is a valid subjective and objective tool to evaluate outcomes of surgical treatment of patients affected by upper and lower extremity tumors

Abstract

Purpose

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusions

Please log in to get access to this content